SCHEMBL1759557

SCHEMBL1759557

O=S(=O)(O)c1c(O)c(S(=O)(=O)O)c2ccccc2c1N=Nc1ccc(N=Nc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.53
▸ POLB P06746 2/20 0.53
▸ KMT2A Q03164 7/20 0.45
▸ MEN1 O00255 6/20 0.45
▸ MAPT P10636 6/20 0.45
▸ TDP1 Q9NUW8 4/20 0.45
▸ MAPK1 P28482 3/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ HSP90AA1 P07900 1/20 0.45
▸ MPL P40238 4/20 0.44
▸ THRB P10828 1/20 0.44
▸ SUMO2 P61956 1/20 0.43
▸ SUMO1 P63165 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP2 Q9HC62 1/20 0.43
▸ SENP1 Q9P0U3 1/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ USP2 O75604 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10398674 0.88 POLB (0.53) CYP2D6POLBKMT2AMEN1MAPT
SCHEMBL1096734 0.88 POLB (0.53) CYP2D6POLBKMT2AMEN1MAPT
SCHEMBL1759503 0.88 POLB (0.53) CYP2D6POLBKMT2AMEN1MAPT
SCHEMBL11668148 0.85 POLB (0.56) CYP2D6POLBKMT2AMEN1MAPT
SCHEMBL1095777 0.84 POLB (0.53) CYP2D6POLBKMT2AMEN1MAPT
SCHEMBL10811806 0.84 SUMO2 (0.50) CYP2D6POLBKMT2AMEN1MAPT
SCHEMBL9770459 0.84 SUMO2 (0.50) CYP2D6POLBKMT2AMEN1MAPT
SCHEMBL1759533 0.80 CYP1A2 (0.55) CYP2D6KMT2AMEN1MAPTTDP1
SCHEMBL23787528 0.77 APP (0.56) CYP2D6POLBKMT2AMEN1MAPT
SCHEMBL23787571 0.76 APP (0.59) CYP2D6POLBKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8449626-B2 Cleaning method THE PROCTER & GAMBLE COMPANY (US) 2013-05-28 — — US disclosed
EP-2561059-A1 DETERGENT COMPOSITION The Procter & Gamble Company (US) 2013-02-27 — — EP disclosed
EP-2510092-A1 FABRIC AND HOME CARE PRODUCTS The Procter & Gamble Company (US) 2012-10-17 — — EP disclosed
EP-2499225-A1 CLEANING METHOD The Procter & Gamble Company (US) 2012-09-19 — — EP disclosed
EP-2496681-A1 HIGH EFFICIENCY CAPSULES COMPRISING BENEFIT AGENT The Procter & Gamble Company (US) 2012-09-12 — — EP disclosed
WO-2011133457-A1 DETERGENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2011-10-27 — — WO disclosed
WO-2011072117-A1 FABRIC AND HOME CARE PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2011-06-16 — — WO disclosed
WO-2011060109-A1 CLEANING METHOD THE PROCTER & GAMBLE COMPANY (US) 2011-05-19 — — WO disclosed
US-20110107527-A1 CLEANING METHOD THE PROCTER & GAMBLE COMPANY 2011-05-12 — — US disclosed
WO-2011056934-A1 HIGH EFFICIENCY CAPSULES COMPRISING BENEFIT AGENT THE PROCTER & GAMBLE COMPANY (US) 2011-05-12 — — WO disclosed
WO-2010030540-A1 PARTICLES COMPRISING A HUEING DYE THE PROCTER & GAMBLE COMPANY (US) 2010-03-18 — — WO disclosed
WO-2010030541-A1 LAUNDRY PARTICLE MADE BY EXTRUSION COMPRISING A HUEING DYE THE PROCTER & GAMBLE COMPANY (US) 2010-03-18 — — WO disclosed
WO-2010030539-A1 LAUNDRY PARTICLE MADE BY EXTRUSION COMPRISING A HUEING DYE AND FATTY ACID SOAP THE PROCTER & GAMBLE COMPANY (US) 2010-03-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110107527-A1 CLEANING METHOD CAT, MPO, LBR CYP2D6 2099/4885POLB 122/4885KMT2A 361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback